NO940135L - Substituerte dialkyltioetere - Google Patents

Substituerte dialkyltioetere

Info

Publication number
NO940135L
NO940135L NO940135A NO940135A NO940135L NO 940135 L NO940135 L NO 940135L NO 940135 A NO940135 A NO 940135A NO 940135 A NO940135 A NO 940135A NO 940135 L NO940135 L NO 940135L
Authority
NO
Norway
Prior art keywords
alkoxy
alkyl
lower alkyl
independently represent
halogen
Prior art date
Application number
NO940135A
Other languages
English (en)
Other versions
NO940135D0 (no
Inventor
Pier Giorgio Ferrini
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO940135D0 publication Critical patent/NO940135D0/no
Publication of NO940135L publication Critical patent/NO940135L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det er beskrevet substituerte dialkyltioetere med formel (I) R, ¿ N ¿ Y O hvor R! kan ha flere betydninger og blant annet bety hydrogen, laveralkyl , hydroksy-laverealkyl , lavereal- koksy-laverealkyl eller laverealkoksy-laverealkoksy- laverealkyl; R2 betyr laverealkyl som eventuelt er substituert, for eksempel med amino, acylamino eller karboksy; R3 og R4 betyr uavhengig av hverandre hydrogen, laverealkyl, halogen, laverealkoksy eller laverealkyltio, R5 og R^, betyr uavhengig av hverandre hydrogen, laverealkyl, halogen-laverealkyl , lavereal- koksy, laverealkyltio, halogen, amino, laverealkylami- no, dilaverealkylamino eller laverealkanoylamino, alk betyr laverealkylen og X og Y betyr uavhengig av hverandre en direkte binding, laverealkylen eller laverealkenylen, samt salter derav. Disse forbindel- sene hemmer biosyntesen av interleukin-1 (IL-1) og oppviser videre analgetiske egenskaper. De kan derfor anvendes som virksomme stoffer i legemidler. Forbind- elsene fremstilles på i og for seg kjent måte.
NO940135A 1993-01-15 1994-01-14 Substituerte dialkyltioetere NO940135L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH11593 1993-01-15

Publications (2)

Publication Number Publication Date
NO940135D0 NO940135D0 (no) 1994-01-14
NO940135L true NO940135L (no) 1994-07-18

Family

ID=4179596

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940135A NO940135L (no) 1993-01-15 1994-01-14 Substituerte dialkyltioetere

Country Status (13)

Country Link
US (1) US5380726A (no)
EP (1) EP0606824A1 (no)
JP (1) JPH06247949A (no)
KR (1) KR940018370A (no)
AU (1) AU5261193A (no)
CA (1) CA2112786A1 (no)
CZ (1) CZ7794A3 (no)
FI (1) FI940154A (no)
HU (1) HUT70936A (no)
IL (1) IL108329A0 (no)
NO (1) NO940135L (no)
SK (1) SK4394A3 (no)
ZA (1) ZA94280B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4441873A1 (de) * 1994-11-24 1996-05-30 Wella Ag Mittel zur dauerhaften Haarverformung
AU5321796A (en) * 1995-03-23 1996-10-08 Affymax Technologies N.V. Novel piperazine derivatives as type il-1 receptor antagonists
FR2740134B1 (fr) * 1995-10-18 1998-01-09 Pf Medicament Derives d'amines cycliques d'aryl-piperazines, leur preparation et les compositions pharmaceutiques les contenant
FR2744449B1 (fr) * 1996-02-02 1998-04-24 Pf Medicament Nouvelles piperazines aromatiques derivees de cycloazanes substitues, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments
FR2744450A1 (fr) * 1996-02-02 1997-08-08 Pf Medicament Nouvelles naphtylpiperazines derivees de cycloazanes substitues, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments
US20050119251A1 (en) * 2001-12-21 2005-06-02 Jian-Min Fu Nicotinamide derivatives and their use as therapeutic agents
GB0224917D0 (en) * 2002-10-25 2002-12-04 Novartis Ag Organic compounds
TW200626139A (en) * 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
TW200626572A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
BRPI0515483A (pt) 2004-09-20 2008-07-22 Xenon Pharmaceuticals Inc derivados heterocìclicos para o tratamento de doenças mediadas por enzimas estearoil-coa desaturase
WO2006034440A2 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
AR051294A1 (es) * 2004-09-20 2007-01-03 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa
BRPI0515488A (pt) 2004-09-20 2008-07-29 Xenon Pharmaceuticals Inc derivados de heterocìclicos e seu uso como agentes terapêuticos
EP1814551A2 (en) 2004-09-20 2007-08-08 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
MX2007003332A (es) * 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de estearoil-coa-desaturasa.
EP2540296A1 (en) * 2005-06-03 2013-01-02 Xenon Pharmaceuticals Inc. Arminothiazole derivatives as human stearoyl-coa desaturase inhibitors
WO2018236745A1 (en) 2017-06-20 2018-12-27 Carnot, Llc COMPOSITIONS AND METHODS FOR INCREASING THE EFFICACY OF CARDIAC METABOLISM
US11780811B2 (en) 2020-06-30 2023-10-10 Imbria Pharmaceuticals, Inc. Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11530184B2 (en) 2020-06-30 2022-12-20 Imbria Pharmaceuticals, Inc. Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11883396B2 (en) 2021-05-03 2024-01-30 Imbria Pharmaceuticals, Inc. Methods of treating kidney conditions using modified forms of trimetazidine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL105768C (no) * 1959-02-25
CH590260A5 (no) * 1973-07-10 1977-07-29 Ciba Geigy Ag
DE2365988B2 (de) * 1973-07-12 1978-09-07 Ludwig Heumann & Co Gmbh, 8500 Nuernberg Verfahren zur Herstellung von N-Dialkylaminoäthyl-2-alkoxy-4-amino-5-chlor-benzoesäureamiden
EP0008072B1 (de) * 1978-08-10 1984-02-22 Ciba-Geigy Ag Substituierte Anthranilsäureamide, Verfahren zu ihrer Herstellung, diese enthaltende pharmazeutische Präparate und ihre Herstellung
MY102447A (en) * 1986-06-16 1992-06-30 Ciba Geigy Ag Disubtituted piperazines
AU606808B2 (en) * 1988-06-29 1991-02-14 Otsuka Pharmaceutical Factory, Inc. Arylcarboxamide substituted by alkylphosphonates, process for preparing the same and a pharmaceutical composition containing the same
US5051423A (en) * 1988-07-13 1991-09-24 Schering Ag Derivatized alkanolamines as cardiovascular agents
EP0385043A1 (en) * 1989-02-28 1990-09-05 Fabrica Espanola De Productos Quimicos Y Farmaceuticos, S.A. (Faes) New derivatives of 4-substituted piperazines
EP0489690A1 (de) * 1990-12-05 1992-06-10 Ciba-Geigy Ag Substituierte N-Benzoyl-N'-(2-phenylethyl)-piperazine
EP0524146A1 (de) * 1991-07-19 1993-01-20 Ciba-Geigy Ag Aminosubstituierte Piperazinderivate

Also Published As

Publication number Publication date
AU5261193A (en) 1994-07-21
IL108329A0 (en) 1994-04-12
ZA94280B (en) 1994-07-05
KR940018370A (ko) 1994-08-16
US5380726A (en) 1995-01-10
EP0606824A1 (de) 1994-07-20
FI940154A0 (fi) 1994-01-12
HU9400118D0 (en) 1994-05-30
FI940154A (fi) 1994-07-16
CA2112786A1 (en) 1994-07-16
HUT70936A (en) 1995-11-28
NO940135D0 (no) 1994-01-14
CZ7794A3 (en) 1994-08-17
SK4394A3 (en) 1994-12-07
JPH06247949A (ja) 1994-09-06

Similar Documents

Publication Publication Date Title
NO940135L (no) Substituerte dialkyltioetere
NO922853L (no) Aminosubstituerte piperazinderivater
GEP20084341B (en) Aminoheteroaryl compounds as protein kinase inhibitors
TW349843B (en) Substituted 1-arylpyrazoles
RS50204A (en) Substituted phenyl derivatives
AU7817094A (en) Stabilisation of proteins in solution
WO2001038324A3 (en) Imidazole derivatives and their use as raf kinase inhibitors
AU2823292A (en) Substituted biphenylpyridones
AU7576896A (en) Lipopolyamines as transfection agents and their pharmaceutical applications
AU560579B2 (en) N-aromatic-n:-cycloalkylalkanoyl-piperazines
WO2002094020A8 (de) Verwendung von triazolopyrimidin-derivaten als mikrobizide im materialschutz
DE59108419D1 (de) Dicarbonsäureimide, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide
HU9402615D0 (en) Fungicidal mixture
WO2000039083A3 (en) Pyrazole compounds and uses thereof
AU3582095A (en) Isothiourea derivatives as no synthase inhibitors
MXPA04009476A (es) Compuestos de (tiazol-4,2-disustituidos-5-il)amina como inhibidores de la pde7.
AU6582394A (en) Novel bisoxadiazolidine derivative
NO982072L (no) Amidin- og isotioureaderivater som inhibitorer av nitrogenoksydsyntase
WO2002088125A3 (de) Triazolopyrimidine mit fungizider wirkung
EP0205022A3 (en) 1-aryl-5-alkoximinoalkyl amino pyrazoles
TR200100133T2 (tr) FKBP İnhibitörleri
CA2098842A1 (en) Use of host cell phospholipids for inhibiting microbial colonization
WO2000039130A3 (en) Prenyl transferase inhibitors
AU4454196A (en) Substituted phenyl compounds as endothelin antagonists
TW325463B (en) 4-Aminobenzoylguanidine-derivatives